Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
SOURCE Research and Markets
DUBLIN, Ireland, February 21, 2014 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/lq9g9z/endocrine_testing) has announced the addition of the "Endocrine Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019" report to their offering.
Endocrine glands and hormones are major elements of the endocrine system that are crucial for regulation of several body mechanisms such as growth, development and homeostasis. Responses to stress, injury, absorption of nutrients maintenance of water and electrolyte balance and energy metabolism constitutes major areas of control and integration offered by the endocrine system. There are endocrine glands (pituitary, pineal, thyroid and others) and secretory organs (pancreas, hypothalamus) that release hormones directly into the blood stream. These glands have rich blood supply which facilitate movement of hormones to reach their target organs and enable various alterations in metabolism of target organs by increasing or decreasing their activity.
Endocrine tests are crucial for monitoring normal functioning of endocrine system since any deviation (hypersecretion or hyposecretion) from the normal levels of hormones results in development of various endocrine disorders such as diabetes, thyroid, cancer and infertility. These tests enable both qualitative and quantitative determination of the hormone levels and can be performed either in hospitals, commercial laboratories (thyroid hormone tests, progesterone tests) or even at home (pregnancy test kit, blood sugar test strips). Endocrine testing market is witnessing increasing growth and adoption majorly due to constant rise in several disorders such as diabetes, thyroid and reproductive system disorders.These disorders indicate the abnormal level of endocrine hormones in the body thereby creating a need and demand for effective endocrine testing kits. In addition, continuous evolution of diagnostic platforms followed by increasing healthcare awareness would further augment the growth and development of endocrine testing platforms. The global market for endocrine testing market was valued at USD 1,537.5 million in 2012 growing at a CAGR of 4.3% from 2013 to 2019.
Endocrine testing market can be analyzed by the type of tests involved, diagnostic platforms and end users. The various hormone tests refer to estradiol, Follicle Stimulating Hormone (FSH), Human Chorionic Gonadotropin (hCG), Luteinizing Hormone (LH), Dehydroepiandrosterone sulfate (DHEAS), Progesterone, Testosterone, Thyroid Stimulating Hormone (TSH), Prolactin, Cortisol, Insulin tests and others. Thyroid stimulating hormone test market was estimated to be the largest market segment in 2012 growing at a CAGR of 5.4% during the forecast period. This is attributed to high prevalence of thyroid disorders among geriatric population and also is more common in females than males with a female to male ratio of 10:1. Also, as per the research findings published in Elsevier, Inc., among the population aged above 65, 1.7% have hypothyroidism and 13.7% of aging population have subclinical hypothyroidism. Insulin test is expected to be the fastest growing segment during the forecast period from 2013 to 2019. The major reason being constant rise in diabetic and obese population across the globe.
Key Topics Covered:
2 Executive Summary
3 Market Overview
4 Endocrine Testing Market, by Test
5 Endocrine Testing Market, by Diagnostic Technologies
6 Endocrine Testing Market, by End Users
7 Endocrine Testing Market, by Geography
8 Competitive Landscape
10 Company Profiles
For more information visit http://www.researchandmarkets.com/research/lq9g9z/endocrine_testing
Media Contact: Laura Wood , +353-1-481-1716, email@example.com
©2012 PR Newswire. All Rights Reserved.